Skip to main content

Research Repository

Advanced Search

Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites

Martinez-Gili, Laura; McDonald, Julie A.K.; Liu, Zhigang; Kao, Dina; Allegretti, Jessica R.; Monaghan, Tanya M.; Barker, Grace F.; Migu�ns Blanco, Jes�s; Williams, Horace R.T.; Holmes, Elaine; Thursz, Mark R.; Marchesi, Julian R.; Mullish, Benjamin H.

Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites Thumbnail


Authors

Laura Martinez-Gili

Julie A.K. McDonald

Zhigang Liu

Dina Kao

Jessica R. Allegretti

TANYA MONAGHAN Tanya.Monaghan@nottingham.ac.uk
Clinical Associate Professor in Luminal Gastroenterology

Grace F. Barker

Jes�s Migu�ns Blanco

Horace R.T. Williams

Elaine Holmes

Mark R. Thursz

Julian R. Marchesi

Benjamin H. Mullish



Abstract

Fecal microbiota transplant (FMT) is a highly-effective therapy for recurrent Clostridioides difficile infection (rCDI), and shows promise for certain non-CDI indications. However, at present, its mechanisms of efficacy have remained poorly understood. Recent studies by our laboratory have noted the particular key importance of restoration of gut microbe-metabolite interactions in the ability of FMT to treat rCDI, including the impact of FMT upon short chain fatty acid (SCFAs) and bile acid metabolism. This includes a significant impact of these metabolites upon the life cycle of C. difficile directly, along with potential postulated additional benefits, including effects upon host immune response. In this Addendum, we first present an overview of these recent advancements in this field, and then describe additional novel data from our laboratory on the impact of FMT for rCDI upon several gut microbial-derived metabolites which had not previously been implicated as being of relevance.

Citation

Martinez-Gili, L., McDonald, J. A., Liu, Z., Kao, D., Allegretti, J. R., Monaghan, T. M., …Mullish, B. H. (2020). Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites. Gut Microbes, 12(1), Article 1810531. https://doi.org/10.1136/gutjnl-2018-317842

Journal Article Type Article
Acceptance Date Aug 3, 2020
Online Publication Date Sep 6, 2020
Publication Date Sep 6, 2020
Deposit Date Aug 12, 2020
Publicly Available Date Sep 7, 2021
Journal Gut Microbes
Print ISSN 1949-0976
Electronic ISSN 1949-0984
Publisher Taylor and Francis
Peer Reviewed Peer Reviewed
Volume 12
Issue 1
Article Number 1810531
DOI https://doi.org/10.1136/gutjnl-2018-317842
Keywords gut microbiome; metabonomics; fecal microbiota transplant; Clostridioides difficile infection; bile acids; short chain fatty acids; trimethylamine
Public URL https://nottingham-repository.worktribe.com/output/4828231
Publisher URL https://www.tandfonline.com/doi/full/10.1080/19490976.2020.1810531

Files









You might also like



Downloadable Citations